StockData
GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP) stock

GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.18−0.35 (-10.04%)

Close on Nov 17, 2026Market cap $143.45MP/E –Yield –

GT Biopharma gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2015 it was 100.0%, against 6.6% the year before. The highest annual figure on record is 100.0% in fiscal 2015.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2015Dec 31, 2015100.0%+93.4
FY2014Dec 31, 20146.6%−32.0
FY2013Dec 31, 201338.6%−33.9
FY2012Dec 31, 201272.5%+157.1
FY2011Dec 31, 2011-84.6%+406.3
FY2010Dec 31, 2010-490.9%–

More GT Biopharma figures

See a number that looks wrong?